• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Newamsterdam Pharma - CW27(NAMSW.US)

Overview
News
Company Encyclopedia
View More
name
Newamsterdam Pharma - CW27
NAMSW.US
Shareholder
Ownership%OwnedShare ChgReport Date
No Data
News
View More

Newamsterdam Pharma - CW27 | 10-Q: FY2025 Q3 Revenue: USD 348 K

LB filings·11/05/2025 21:04
US
NAMSW
0.00%
LB filings·11/05/2025 21:04
US
NAMSW
0.00%

Newamsterdam Pharma - CW27 | 8-K: FY2025 Q3 Revenue: USD 348 K

LB filings·11/05/2025 21:03
US
NAMSW
0.00%
LB filings·11/05/2025 21:03
US
NAMSW
0.00%

Newamsterdam Pharma - CW27 | 10-Q: FY2025 Q2 Revenue: USD 19.15 M

LB filings·08/06/2025 19:01
US
NAMSW
0.00%
LB filings·08/06/2025 19:01
US
NAMSW
0.00%

Newamsterdam Pharma - CW27 | 8-K: FY2025 Q2 Revenue: USD 19.15 M

LB filings·08/06/2025 19:01
US
NAMSW
0.00%
LB filings·08/06/2025 19:01
US
NAMSW
0.00%

Newamsterdam Pharma - CW27 | 10-Q: FY2025 Q1 Revenue: USD 2.978 M

LB filings·05/08/2025 20:02
US
NAMSW
0.00%
LB filings·05/08/2025 20:02
US
NAMSW
0.00%
© 2026 Longbridge|Disclaimer